Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Ashok Krishnamurthi
AddedMar 31, 2024
UpdatedJun 28, 2026
Ashok Krishnamurthi

Ashok Krishnamurthi

Board Member, Linus Biotechnology

CrunchbaseLinkedIn

Ashok Krishnamurthi's Career

Linus Biotechnology
Linus Biotechnology

New Rochelle, NY, US

Board Member· Board
K2 Cyber Security
K2 Cyber Security

San Jose, CA, US

Board Member· Board
Recogni
Recogni

San Jose, CA, US

Board Member· Board
KlearNow
KlearNow

Santa Clara, CA, US

Board Member· Board
Excision BioTherapeutics
Excision BioTherapeutics

Philadelphia, PA, US

Board Member· Board
Namogoo
Namogoo

Boston, MA, US

Board Member· Board
Truvian
Truvian

San Diego, CA, US

Board Member· Board
Activ Surgical
Activ Surgical

Boston, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Ashok Krishnamurthi's Career

Linus Biotechnology
Linus Biotechnology

New Rochelle, NY, US

Board Member· Board
K2 Cyber Security
K2 Cyber Security

San Jose, CA, US

Board Member· Board
Recogni
Recogni
Series B$73.9M882017San Jose, CA, US
Board Member· Board

Leadership at Recogni

Peter MertensPeter MertensBoard Member
Eugene FeinbergEugene FeinbergCo-Founder
Valerie ChanValerie ChanCo-Founder
Gilles BackhusGilles BackhusCo-Founder
Ashwini ChoudharyAshwini ChoudharyCo-Founder
Marc BolithoMarc BolithoCEO

Similar to Recogni

SensifaiSensifaiCity of Brussels, Flemish Brabant, BEVideo Recognitionest. 2016SensifaiCity of Brussels, Flemish Brabant, BE · est. 2016

Sensifai, a leading provider of comprehensive video recognition systems.

Seed · $1.3M36
Analog InferenceAnalog InferenceSanta Clara, CA, USHardware, Softwareest. 2018Analog InferenceSanta Clara, CA, US · est. 2018

Analog Inference, a software and hardware firm, pioneers in neural computing with innovative products.

Series B · $50.5M47
ClarifaiClarifaiNew York City, NY, USAI Platform, Image Recognitionest. 2013ClarifaiNew York City, NY, US · est. 2013

Clarifai Inc specializes in advanced computer vision, offering image recognition systems for visual search and detection.

Series C · $100M90
RecognizeRecognizeNew York City, NY, USTechnology ServicesRecognizeNew York City, NY, US

Recognize, a tech company builder, partners with skilled teams to spur innovation with industry insight, expertise, and capital.

5
KlearNow
KlearNow
Series B$66M3022018Santa Clara, CA, US
Board Member· Board

Leadership at KlearNow

Ulf SandbergUlf SandbergCo-Founder
Mark RandallMark RandallBoard Member
Rick TellezRick TellezCo-Founder
Nishita CummingsNishita CummingsBoard Member
Sam TyagiSam TyagiBoard Member

Similar to KlearNow

Zeus LogicsZeus LogicsNew York City, NY, USLogistics, Supply Chainest. 2019Zeus LogicsNew York City, NY, US · est. 2019

Zeus: Digital customs brokerage and global supply chain solutions provider.

Seed · $1.9M13
GlobatomGlobatomSeattle, WA, USFreight Forwardingest. 2013GlobatomSeattle, WA, US · est. 2013

Globatom: Streamlining logistics with cloud-based tech for transparent, efficient freight forwarding.

Seed · $785k2
NabuNabuStrasbourg, Bas-Rhin, FRDocument Processingest. 2018NabuStrasbourg, Bas-Rhin, FR · est. 2018

Nabu: Streamlining customs formalities through automated document processing and efficient data management.

Seed · $2M8
ReformReformNew York City, NY, USLogistics Softwareest. 2023ReformNew York City, NY, US · est. 2023

Reform: NYC-based software for logistics automation and internal tools creation.

Pre-Seed · $500k3
Excision BioTherapeutics
Excision BioTherapeutics
Series A$77.6M512015Philadelphia, PA, US
Board Member· Board

Leadership at Excision BioTherapeutics

Tom MalcolmTom MalcolmCo-Founder
Nicole PaulkNicole PaulkBoard Member
William CarsonWilliam CarsonBoard Member
Daniel DornbuschDaniel DornbuschBoard Member
Vasudev BaileyVasudev BaileyBoard Member
Jeff KindlerJeff KindlerBoard Member

Similar to Excision BioTherapeutics

TherabiolTherabiolSan Francisco, CA, USImmune Therapiesest. 2012TherabiolSan Francisco, CA, US · est. 2012

Therabiol, Inc.: A San Francisco-based biotech firm specializing in developing immune therapies for viral infections.

Seed · $150k5
ExcepgenExcepgenSan Francisco, CA, USGene Therapies, Vaccinesest. 2018ExcepgenSan Francisco, CA, US · est. 2018

ExcepGen: A San Francisco-based biotech firm innovating in drug discovery for next-gen therapeutics.

Seed · $4.2M6
Exegenesis BioExegenesis BioLansdale, PA, USGene Therapyest. 2019Exegenesis BioLansdale, PA, US · est. 2019

Exegenesis: A global leader in gene therapy, innovating new medicines for China and worldwide.

Series B · $10M17
Namogoo
Namogoo
Series C$69M1352014Boston, MA, US
Board Member· Board

Leadership at Namogoo

Ohad GreenshpanOhad GreenshpanCo-Founder
Matt StreisfeldMatt StreisfeldBoard Member
Alon LifshitzAlon LifshitzBoard Member
David J. BlumbergDavid J. BlumbergBoard Member
Chemi KatzChemi KatzCo-Founder
Yodfat Harel BuchrisYodfat Harel BuchrisBoard Member
Truvian
Truvian
Series C$134.1M1282015San Diego, CA, US
Board Member· Board

Leadership at Truvian

Jean-Pierre MillonJean-Pierre MillonBoard Member
Paul MeisterPaul MeisterBoard Member
Kim KamdarKim KamdarBoard Member
Randal (Randy) ErmanRandal (Randy) ErmanCo-Founder
Megh GuptaMegh GuptaBoard Member
Jay SrinivasanJay SrinivasanCEO
Activ Surgical
Activ Surgical
Series B$100.4M812017Boston, MA, US
Board Member· Board

Leadership at Activ Surgical

Manisha Shah-BugajManisha Shah-BugajCEO
Ameena El-BibanyAmeena El-BibanyBoard Member
Emily CaseyEmily CaseyBoard Member
Seth TeicherSeth TeicherCo-Founder
Peter KimPeter KimCo-Founder

Similar to Activ Surgical

Surgical AutomationsSurgical AutomationsDallas, TX, USSurgical Robotsest. 2023Surgical AutomationsDallas, TX, US · est. 2023

Surgical Automations: Developing AI-powered surgical robots for precise endoscopic procedures.

Pre-Seed · $835k3
Asensus SurgicalAsensus SurgicalDurham, NC, USSurgical Systemsest. 2006Asensus SurgicalDurham, NC, US · est. 2006

Asensus Surgical, Inc. enhances minimally invasive surgery with digital, robotic, and AI laparoscopy solutions.

Public · $454.6M197
Zeta SurgicalZeta SurgicalBoston, MA, USRobotics, Surgical Navigationest. 2018Zeta SurgicalBoston, MA, US · est. 2018

Zeta Surgical: Innovating minimally invasive surgery with advanced navigation and robotics.

Seed · $8.8M10
XSurgical RoboticsXSurgical RoboticsCambridge, MA, USSurgical Instruments, Surgical Robotsest. 2009XSurgical RoboticsCambridge, MA, US · est. 2009

XSurgical: Innovating surgical practice with advanced robotic instruments and technology.

Angel · $54.8k30

Ashok Krishnamurthi's Co-Investors

Ross Perot JrRoss Perot JrCo-invested · American Cricket Enterprises Seed · 2 dealsRohyt BelaniRohyt BelaniCo-invested · American Cricket Enterprises SeedAmit SinghalAmit SinghalCo-invested · American Cricket Enterprises SeedNeeraj AroraNeeraj AroraCo-invested · American Cricket Enterprises SeedRaju ReddyRaju ReddyCo-invested · American Cricket Enterprises SeedSanjay GovilSanjay GovilCo-invested · American Cricket Enterprises SeedShantanu NarayenShantanu NarayenCo-invested · American Cricket Enterprises SeedManoj BahetiManoj BahetiCo-invested · American Cricket Enterprises Seed

Ashok Krishnamurthi's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Ashok Krishnamurthi

Prabhat Kumar SinghPrabhat Kumar SinghFounder · PikMeJeff McLarenJeff McLarenBoard Member · HealthStreamRobert Edward GrantRobert Edward GrantBoard Member · ReShape MedicalScott JensScott JensBoard Member · ThirdSpaceAlan LucasAlan LucasFounder & CEO · Navigation SciencesJeffrey AbbottJeffrey AbbottBoard Member · CytoTronics